BETA: Please send your feedback!

Aclaris Therapeutics

NAS:ACRS

Pharmaceuticals: Other

$304.57mm
SMALL cap
$7.36 (-1.14%)
-2.8721%
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5

About

Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in identifying, developing and commercializing novel drugs to address unmet needs in dermatology. It also pursues the development of topical agents for the treatment and prevention of a number of medical and cosmetic indications. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.
website

Headquarters

101 Lindenwood Drive
Suite 400
Malvern, PA 19355

Executives

Name Title Gender
Neal S. Walker, PhD, MBA President, Chief Executive Officer & Director Male
Michael Stephen Tung, MD, MBA Vice President-Investor Relations Male
Stephen A. Tullman Chairman Male
Kamil Ali-Jackson Chief Legal Officer Female
Frank Ruffo, CPA Chief Financial Officer Male
Christopher V. Powala Chief Operating Officer Male
Stuart D. Shanler, MD Chief Scientific Officer Male

Mindful Investing Summary

  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint N/A
  • Pollution Prevention N/A
  • Water Conservation N/A
  • Data & Privacy Protection N/A
  • Consumer Health, Wellness & Safety N/A
  • Employee Ownership, Satisfaction, Benefits & Pay N/A
  • Workplace Health and Safety N/A
  • Integrity of Corporate Governance N/A
  • Ethical Practices N/A
  • Usage of Conflict Materials N/A
  • Forced Labor N/A
  • Diversity of Corporate Leadership 2

Aclaris Therapeutics - Competitors and Related Companies

How Aclaris Therapeutics stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.

Aclaris Therapeutics

NAS:ACRS

Pharmaceuticals: Other

$304.57mm
SMALL cap
$7.36 (-1.14%)
-2.8721%
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5
Loading…